Arkfeld Wealth Strategies’s Eli Lilly LLY Stock Holding History

Arkfeld Wealth Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Buy	580 +1	+0.2%	+$1.02K	0.21%	56
2026 Q1	$524K	Hold	579	–	–	0.17%	64
2025 Q4	$642K	Hold	579	–	–	0.22%	51
2025 Q3	$486K	Hold	579	–	–	0.18%	58
2025 Q2	$447K	Buy	579 +1	+0.2%	+$777	0.18%	59
2025 Q1	$436K	Hold	578	–	–	0.19%	61
2024 Q4	$461K	Sell	578 -60	-9%	-$49.7K	0.21%	53
2024 Q3	$566K	Hold	638	–	–	0.27%	49
2024 Q2	$585K	Buy	638 +1	+0.2%	+$800	0.3%	54
2024 Q1	$486K	Hold	637	–	–	0.27%	52
2023 Q4	$398K	Hold	637	–	–	0.26%	54
2023 Q3	$369K	Hold	637	–	–	0.27%	50
2023 Q2	$281K	Buy	637 +13	+2%	+$5.45K	0.2%	62
2023 Q1	$227K	Hold	624	–	–	0.16%	68
2022 Q4	$220K	Hold	624	–	–	0.14%	71
2022 Q3	$207K	Hold	624	–	–	0.14%	67
2022 Q2	$206K	Buy	+624	New	+$187K	0.13%	65

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arkfeld Wealth Strategies's LLY Position: Q2 2026 in Review

Arkfeld Wealth Strategies increased its Eli Lilly (LLY) stake by 0.17% in Q2 2026, buying an estimated $1.02K and bringing the position to 580 shares worth $696K. The position accounts for 0.21% of the portfolio, ranked #56.

Arkfeld Wealth Strategies first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Arkfeld Wealth Strategies held 580 shares of Eli Lilly worth $696K as of Q2 2026.
Arkfeld Wealth Strategies bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
Eli Lilly made up 0.21% of Arkfeld Wealth Strategies's portfolio in Q2 2026, its #56 holding.
Arkfeld Wealth Strategies first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arkfeld Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.